glp 1 antagonist exendin Exendin(9‐39)NH2: Recommendations for clinical use based on a systematic literature review - Gasbjerg - 2021 - Diabetes, Obesity and Metabolism 1 receptor (GLP exenatide [TUSOM | Pharmwiki]

These drugs are primarily approved for treating type 2 diabetes, so coverage is usually only available if a patient with PCOS also has type 2 diabetes or obesity as a related condition

Personalized Side Effect Management With PlexusDx Precision Peptide Genetic Testing The PlexusDx Precision Peptide Genetic Test analyzes GLP1R variants that relate to GLP-1 and related signaling pathways

There are case reports of patients developing severe symptoms that resolved after discontinuing GLP 1 supplements

PB serves on the advisory board of XORTX

These agents now have indication to provide cardiovascular benefits, and they show promise in improving kidney and liver health while on GLP-1 treatment, making assessment of cardiometabolic disease critical before, during, and after therapy